KUMAR AMIT
Transaction: 09/10/2026
BUY
Change
+5,000
Price
$2.76
Filing
09/11/2026
Type
BUY
Anixa Biosciences, Inc.
ANIX • Biotechnology
$2.68
▲ +0.07 (+2.68%)
Current price
EarningsLatest report: Jul 31, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$91.61M
Growth
-100.0%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.01Healthy liquidity · 8.08Negative growth trendWeak profitability
Financial data as of: Jul 31, 2026, 12:00 AM UTCLast earnings update: Jul 31, 2026, 12:00 AM UTCLast profile update: Sep 11, 2026, 12:10 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$2.68
Change2.68%
Shares Out34.18M
Market Cap$91.61M
Enterprise Value$77.92M
52W Range2.32 - 5.46
Beta0.60
P/E-11.72
P/B6.33
P/FCF-12.42
EV/EBITDA-7.16
EV/FCF-10.56
Price$2.68
Change2.68%
Shares Out34.18M
Market Cap$91.61M
Enterprise Value$77.92M
52W Range2.32 - 5.46
Beta0.60
P/E-11.72
P/B6.33
P/FCF-12.42
EV/EBITDA-7.16
EV/FCF-10.56
Earnings Yield-8.53%
FCF Yield-8.05%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.01
Current Ratio8.08
Quick Ratio8.08
Revenue 5Y-100.00%
Target$6.00
Target Upside123.88%
Target Median$6.00
Target Range6.00 - 6.00
Volume399.34K
Avg Volume235.09K
EPS Surprise0.03
Investment DNA
How strong this company looks for long-term investors
31
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
30/100
Why this score▼
Manageable debt level · 0.01Healthy liquidity · 8.08Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 6 analyst votes · 2026-10-21
100/100
Bullish
Bullish
6
Hold
0
Bearish
0
Price Target
2026-09-11
Low
$3.50
Mean
$5.83
Median
$4.00
High
$10.00
Insider Transactions
Recent executive and insider activity
KUMAR AMIT
Transaction: 07/31/2026
BUY
Change
+5,000
Price
$3.47
Filing
08/03/2026
Type
BUY
Baskies Arnold M
Transaction: 07/27/2026
SELL
Change
-6,000
Price
$3.13
Filing
07/29/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| KUMAR AMIT | BUY | +5,000 | $2.76 | 09/10/2026 | 09/11/2026 |
| KUMAR AMIT | BUY | +5,000 | $3.47 | 07/31/2026 | 08/03/2026 |
| Baskies Arnold M | SELL | -6,000 | $3.13 | 07/27/2026 | 07/29/2026 |
| Baskies Arnold M | SELL | -5,428 | $3.46 | 07/27/2026 | 07/29/2026 |
| KUMAR AMIT | BUY | +5,000 | $3.44 | 07/27/2026 | 07/28/2026 |
| KUMAR AMIT | BUY | +3,188 | $3.37 | 07/27/2026 | 07/27/2026 |
| KUMAR AMIT | BUY | +3,000 | $3.73 | 07/24/2026 | 07/27/2026 |
| KUMAR AMIT | BUY | +5,000 | $3.46 | 07/20/2026 | 07/21/2026 |
| Titterton Lewis H jr | BUY | +12,000 | $3.47 | 07/20/2026 | 07/20/2026 |
| Titterton Lewis H jr | BUY | +2,797 | $3.28 | 07/15/2026 | 07/16/2026 |
| KUMAR AMIT | BUY | +5,000 | $3.04 | 07/10/2026 | 07/13/2026 |
| Titterton Lewis H jr | BUY | +2,836 | $2.64 | 06/16/2026 | 06/17/2026 |
| KUMAR AMIT | BUY | +21,000 | $2.50 | 06/12/2026 | 06/16/2026 |
| Baskies Arnold M | BUY | +10,000 | $3.04 | 01/28/2026 | 01/29/2026 |
| Baskies Arnold M | BUY | +25,000 | $3.18 | 01/05/2026 | 01/06/2026 |
| Catelani Michael | BUY | +175,000 | $3.18 | 01/05/2026 | 01/06/2026 |
| Gottschalk Emily | BUY | +25,000 | $3.18 | 01/05/2026 | 01/06/2026 |
| KUMAR AMIT | BUY | +350,000 | $3.18 | 01/05/2026 | 01/06/2026 |
| Titterton Lewis H jr | BUY | +25,000 | $3.18 | 01/05/2026 | 01/06/2026 |
| Titterton Lewis H jr | SELL | -16,000 | $2.92 | 12/15/2025 | 12/16/2025 |